Multiple-effect water still for pharmaceutical applications
In pharmaceutical manufacturing, the production of water for injection (WFI) requires stringent standards to ensure purity and safety. Achieving this level of quality using efficient and reliable technology is critical in maintaining compliance and product integrity.
Produce high-quality water for injection
The Finn-Aqua® T-Series Multiple-Effect Water Still from Steris utilizes an advanced falling film evaporation technology to remove impurities efficiently. This system operates through a staged evaporation and condensation process, where plant steam is initially applied to the first column evaporator. Subsequent columns use steam produced in the previous column, ensuring high energy efficiency. Only the condenser receives cooling water, which then condenses pure steam into WFI. The patented three-stage pyrogen separation and continuous blowdown removal from each distillation column guarantee the highest WFI quality. Equipped with the latest PLC controls and commercially available components, the system is easy to maintain and validate, making it a cost-effective and reliable choice for pharmaceutical manufacturers.
Benefits
- Reduced energy consumption due to patented column design
- High purity water for injection with three-stage pyrogen separation
- Lower maintenance costs with commercial components
- Proportional capacity control for optimized operation
- Pre-validated units for easy compliance